Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors

In this online program based on a series of CLL Webinars experts discuss evidence-based best practices in using BTK inhibitors to treat patients with CLL. Watch the on-demand Webcast and download the slides now.

Share

Program Content

Activities

CLL BTKi Therapy: FAQ Part 1
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2020

Expires: September 16, 2021

CLL BTKi Therapy: FAQ Part 2
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2020

Expires: September 15, 2021

CLL BTKi Therapy: FAQ Part 3
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2020

Expires: September 16, 2021

Activities

CLL New Horizons With BTKi
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors
Congratulations: You achieved a completion on 04/09/2022

Activities

Prognostic Testing in CLL
Prognostic Marker Testing in Treatment-Naive Patients With CLL—Still Important
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2020

Expires: September 21, 2021

MRD Evaluation in CLL
Considering the Role of MRD Evaluation for Patients With CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 29, 2020

Expires: September 28, 2021

Noncovalent BTKi
Overcoming BTK Resistance in CLL With Noncovalent BTK Inhibitors—Where We Are
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2020

Expires: September 24, 2021

Activities

<i>EP</i>: BTK Inhibitors in CLL
ExpressPoints Chronic Lymphocytic Leukemia: New Horizons with BTK Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2020

Expires: July 09, 2021

BCR Pathway and BTK
Overview of the BCR Pathway and BTK in Tumor Development
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2020

Expires: June 09, 2021

Future Directions for BTKi
BTK Inhibitors: Future Directions
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2020

Expires: June 09, 2021

BTK Inhibitors in TN CLL
BTK Inhibitors in Treatment-Naive CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2020

Expires: June 09, 2021

BTK Inhibitors in RR CLL
BTK Inhibitors in Relapsed/Refractory CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2020

Expires: June 09, 2021

Faculty

cover img faculity

Danielle M. Brander, MD

Medical Instructor
Division of Hematologic Malignancies & Cellular Therapy
Department of Medicine
Duke University
Attending Physician, Hematologic Malignancies
Duke University Health System
Durham, North Carolina

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca